Invest now

Marksans Pharma Cash Flow Annual

BSE: 524404 | NSE: MARKSANS | ISIN: INE750C01026 | Sector: Biotechnology & Drugs
329.00 -1.45 (-0.44%)Updated : 11 Sep 2026
Research on
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Issuance( Retirement)of Debt Net -31.89-35.57-40.90-15.48
Net Changein Cash 138.3592.5120.84176.03
Cash Taxes Paid 139.65125.90122.3563.01
Net Income/ Starting Line 560.56503.97423.53337.65
Total Cash Dividends Paid -36.25-27.19-22.66-10.17
Changesin Working Capital -202.11-366.67-248.54-174.48
Cashfrom Operating Activities 458.13206.66230.41237.41
Cash Interest Paid 2.792.395.176.07
Cashfrom Financing Activities -70.93-65.15-68.73197.83
Depreciation/ Depletion 98.6383.3974.2751.85
Other Investing Cash Flow Items Total -117.74123.9168.00-205.58
Capital Expenditures -130.53-172.92-208.84-53.63
period Type ----
Foreign Exchange Effects -0.58-0.000.00
Non- Cash Items 1.05-14.02-18.8522.38
Financing Cash Flow Items -2.79-2.39-5.17-6.07
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -248.27-49.01-140.84-259.21
Issuance( Retirement)of Stock Net --0.00229.54
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,260.00+20.50(1.65%)
11,053.00+157.00(1.44%)
1,196.80-29.75 (-2.43%)
185.95-2.60 (-1.38%)